Short Interest in Pasithea Therapeutics Corp. (NASDAQ:KTTA) Drops By 56.0%
Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 5,100 shares, a decrease of 56.0% from the October 31st total of 11,600 shares. Currently, 0.6% of the company’s shares are short sold. Based on an […]
More Stories
Truist Financial (NYSE:TFC) Price Target Raised to $51.00
Truist Financial (NYSE:TFC – Free Report) had its price target lifted by Citigroup from $47.00 to $51.00 in a report...
Rosenblatt Securities Reiterates Neutral Rating for Brightcove (NASDAQ:BCOV)
Rosenblatt Securities reaffirmed their neutral rating on shares of Brightcove (NASDAQ:BCOV – Free Report) in a research note published on...
Barclays Boosts nCino (NASDAQ:NCNO) Price Target to $44.00
nCino (NASDAQ:NCNO – Free Report) had its target price upped by Barclays from $34.00 to $44.00 in a report released...
JPMorgan Chase & Co. Cuts Boeing (NYSE:BA) Price Target to $190.00
Boeing (NYSE:BA – Free Report) had its price objective cut by JPMorgan Chase & Co. from $195.00 to $190.00 in...
Oppenheimer Forecasts Strong Price Appreciation for AppLovin (NASDAQ:APP) Stock
AppLovin (NASDAQ:APP – Free Report) had its price objective lifted by Oppenheimer from $260.00 to $480.00 in a report released...
Salesforce (NYSE:CRM) Price Target Raised to $380.00
Salesforce (NYSE:CRM – Free Report) had its price objective increased by Truist Financial from $315.00 to $380.00 in a research...